Latest Personalized medicine Stories
OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the
CAMBRIDGE, Mass., Sept.
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the
SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY).
Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif., Sept.
Selected to Showcase Healthcare Innovation at TEDMED WASHINGTON, Sept.
- Findings and research approach published in Nature Communications - CAMBRIDGE, Mass., Sept.
ReportsnReports.com adds "Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical
- A political dynamiter.